Marc Beer Biography and Net Worth

Chairman of biote


Marc Beer brings more than 25 years of development and commercialization experience in biotechnology, pharmaceutical, device, and diagnostics and has served as CEO of Aegerion Pharmaceuticals, Inc. and ViaCell and as a member of the Erytech Pharma Board of Directors.

A member of the Miami University Business Advisory Council, Mark previously served as a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council.

Marc has led several companies through significant capital raises and public offerings, including Renovia, LumeNXT Inc., Origami Surgical, Liftique, and Minerva Neurosciences Inc. His extensive experience as a Founder, CEO, and Chairman in numerous health-related companies makes him an ideal contributor to support Biote’s growth initiatives.

What is Marc D. Beer's net worth?

The estimated net worth of Marc D. Beer is at least $275.21 thousand as of August 10th, 2026. Mr. Beer owns 223,744 shares of biote stock worth more than $275,205 as of September 25th. This net worth evaluation does not reflect any other assets that Mr. Beer may own. Learn More about Marc D. Beer's net worth.

How do I contact Marc D. Beer?

The corporate mailing address for Mr. Beer and other biote executives is 1875 W. Walnut Hill LN #100, Irving, TX, 75038. biote can also be reached via phone at (972) 486-9346 and via email at [email protected]. Learn More on Marc D. Beer's contact information.

Has Marc D. Beer been buying or selling shares of biote?

Within the last three months, Marc D. Beer has bought $202,203.50 in biote stock. Most recently, on Tuesday, August 11th, Marc D. Beer bought 16,000 shares of biote stock. The stock was acquired at an average cost of $1.55 per share, with a total value of $24,800.00. Following the completion of the transaction, the chairman now directly owns 239,744 shares of the company's stock, valued at $371,603.20. Learn More on Marc D. Beer's trading history.

Who are biote's active insiders?

biote's insider roster includes Marc Beer (Chairman), Marc Beer (Chairman), Stephen Cone (Director), and Robert Peterson (CFO). Learn More on biote's active insiders.

Are insiders buying or selling shares of biote?

In the last twelve months, biote insiders bought shares 2 times. They purchased a total of 131,950 shares worth more than $202,203.50. The most recent insider tranaction occured on August, 11th when Chairman Marc D. Beer bought 16,000 shares worth more than $24,800.00. Insiders at biote own 32.4% of the company. Learn More about insider trades at biote.

Information on this page was last updated on 8/11/2026.

Marc D. Beer Insider Trading History at biote

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2026Buy16,000$1.55$24,800.00239,744View SEC Filing Icon  
8/10/2026Buy115,950$1.53$177,403.50223,744View SEC Filing Icon  
See Full Table

Marc D. Beer Buying and Selling Activity at biote

This chart shows Marc D. Beer's buying and selling at biote by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

biote Company Overview

biote logo
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Read More

Today's Range

Now: $1.24
Low: $1.22
High: $1.25

50 Day Range

MA: $1.70
Low: $1.23
High: $2.52

2 Week Range

Now: $1.24
Low: $1.21
High: $3.26

Volume

12,959 shs

Average Volume

252,952 shs

Market Capitalization

$44.37 million

P/E Ratio

11.23

Dividend Yield

N/A

Beta

1.6